Ligand profile
ZINC2276110
Virtual-screening candidate from ZINC.
Bound to: KP13_01311 — Methylmalonate semialdehyde dehydrogenase acylating
Identifiers
Database identifiers and provenance.
- Ligand ID
ZINC2276110- UniProt (similar protein)
P00352- Tanimoto
- 1.000
- Target protein
- KP13_01311
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 37.4
- −1 ≤ LogP ≤ 5 3.72
- MW ≤ 500 Da 306.1
- LogP ≤ 5 3.72
- H-bond donors ≤ 5 0
- H-bond acceptors ≤ 10 2
- Rotatable bonds ≤ 10 2
- TPSA ≤ 140 Ų 37.4
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
O=C1C(=O)N(Cc2ccc(Cl)c(Cl)c2)c2ccccc21O=C1C(=O)N(Cc2ccc(Cl)c(Cl)c2)c2ccccc21
InChI=1S/C15H9Cl2NO2/c16-11-6-5-9(7-12(11)17)8-18-13-4-2-1-3-10(13)14(19)15(18)20/h1-7H,8H2InChI=1S/C15H9Cl2NO2/c16-11-6-5-9(7-12(11)17)8-18-13-4-2-1-3-10(13)14(19)15(18)20/h1-7H,8H2
KGRJPLRFGLMQMV-UHFFFAOYSA-NKGRJPLRFGLMQMV-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Query
- CHEMBL375126
- Homolog
- P00352
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ZINC ZINC15 ZINC2276110 →
- ZINC ZINC20 ZINC2276110 →
- UniProt UniProt P00352 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ZINC2276110”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_01311.
PDB 11
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 100
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 49
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).